The application of transcriptional blood signatures to enhance our understanding of the host response to infection: The example of tuberculosis

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 369, Issue 1645, 2014, Pages

  Blankley, Simon ^a   Berry, Matthew Paul Reddoch ^a,b,c   Graham, Christine M ^a   Bloom, Chloe I ^a   Lipman, Marc ^d,e   O'Garra, Anne ^a,c  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Immune response; Infection; Tuberculosis

Indexed keywords

IMMUNE RESPONSE; MORBIDITY; MORTALITY; PUBLIC HEALTH; TUBERCULOSIS; VACCINATION;

BIOLOGICAL MARKER; TRANSCRIPTOME;

ANTIBIOTIC RESISTANCE; BLOOD; COMMUNICABLE DISEASES; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; MICROBIOLOGY; PHYSIOLOGY; PROCEDURES; SYSTEMS BIOLOGY; TUBERCULOSIS;

BIOMARKERS; COMMUNICABLE DISEASES; DRUG RESISTANCE, MICROBIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; SYSTEMS BIOLOGY; TRANSCRIPTOME; TUBERCULOSIS;

EID: 84961146311     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2013.0427     Document Type: Article

References (77)

1. Pascual V, Chaussabel D, Banchereau J. 2010 A genomic approach to human autoimmune diseases. Annu. Rev. Immunol. 28, 535-571. (doi:10.1146/ annurev-immunol-030409-101221)
2. Chaussabel D, Pascual V, Banchereau J. 2010 Assessing the human immune system through blood transcriptomics. BMC Biol. 8, 84. (doi:10. 1186/1741-7007-8-84)
3. Mejias A, Ramilo O. 2013 Transcriptional profiling in infectious diseases: ready for prime time? J. Infect. 68, S94-S99. (doi:10.1016/j.jinf.2013.09.018)
4. Khatri P, Sirota M, Butte AJ. 2012 Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput. Biol. 8, e1002375. (doi:10.1371/journal.pcbi.1002375)
5. Germain RN, Meier-Schellersheim M, Nita-Lazar A, Fraser ID. 2011 Systems biology in immunology: a computational modeling perspective. Annu. Rev. Immunol. 29, 527-585. (doi:10.1146/annurevimmunol-030409-101317)
6. Zak DE, Aderem A. 2009 Systems biology of innate immunity. Immunol. Rev. 227, 264-282. (doi:10. 1111/j.1600-065X.2008.00721.x)
7. Slonim DK. 2002 From patterns to pathways: gene expression data analysis comes of age. Nat. Genet. 32, 502-508. (doi:10.1038/ng1033)
8. Golub TR et al. 1999 Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537. (doi:10.1126/science.286.5439.531)
9. Obermoser G et al. 2013 Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 38, 831-844. (doi:10.1016/j.immuni.2012.12.008)
10. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, Brown PO. 2003 Individuality and variation in gene expression patterns in human blood. Proc. Natl Acad. Sci. USA 100, 1896-1901. (doi:10.1073/pnas.252784499)
11. Mohr S, Liew CC. 2007 The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol. Med. 13, 422-432. (doi:10.1016/j.molmed.2007.08.003)
12. Rougemont A, Boisson ME. 1975 Letter: racial differences in leucoyte count. Br. Med. J. 2, 684-685. (doi:10.1136/bmj.2.5972.684-c)
13. Lovén J, Orlando DA, Sigova AA, Lin CY, Rahl PB, Burge CB, Levens DL, Lee TI, Young RA. 2012 Revisiting global gene expression analysis. Cell 151, 476-482. (doi:10.1016/j.cell. 2012.10.012)
14. Hu X, Yu J, Crosby SD, Storch GA. 2013 Gene expression profiles in febrile children with defined viral and bacterial infection. Proc. Natl Acad. Sci. USA 110, 12 792-12 797. (doi:10.1073/pnas. 1302968110)
15. Berry MP et al. 2010 An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973-977. (doi:10. 1038/nature09247)
16. Bloom CI et al. 2013 Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PLoS ONE 8, e70630. (doi:10.1371/journal. pone.0070630)
17. Ottenhoff TH et al. 2012 Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis. PLoS ONE 7, e45839. (doi:10.1371/journal.pone. 0045839)
18. + T cells predicts prognosis in patients with Crohn disease and ulcerative colitis. J. Clin. Invest. 121, 4170-4179. (doi:10.1172/JCI59255)
19. Nakaya HI et al. 2011 Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 12, 786-795. (doi:10.1038/ni.2067)
20. Shen-Orr SS, Gaujoux R. 2013 Computational deconvolution: extracting cell type-specific information from heterogeneous samples. Curr. Opin. Immunol. 25, 571-578. (doi:10.1016/j.coi. 2013.09.015)
21. Medzhitov R, Horng T. 2009 Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 9, 692-703. (doi:10.1038/nri2634)
22. Nau GJ, Richmond JF, Schlesinger A, Jennings EG, Lander ES, Young RA. 2002 Human macrophage activation programs induced by bacterial pathogens. Proc. Natl Acad. Sci. USA 99, 1503-1508. (doi:10. 1073/pnas.022649799)
23. Chaussabel D et al. 2008 A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29, 150-164. (doi:10.1016/j.immuni.2008.05.012)
24. Pankla R, Buddhisa S, Berry M, Blankenship DM, Bancroft GJ, Banchereau J, Lertmemongkolchai G, Chaussabel D. 2009 Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol. 10, R127. (doi:10.1186/ gb-2009-10-11-r127)
25. Bloom CI et al. 2012 Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy. PLoS ONE 7, e46191. (doi:10.1371/journal.pone.0046191)
26. Chaussabel D, Allman W, Mejias A, Chung W, Bennett L, Ramilo O, Pascual V, Palucka AK, Banchereau J. 2005 Analysis of significance patterns identifies ubiquitous and disease-specific geneexpression signatures in patient peripheral blood leukocytes. Ann. NY Acad. Sci. 1062, 146-154. (doi:10.1196/annals.1358.017)
27. Ramilo O et al. 2007 Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109, 2066-2077. (doi:10.1182/ blood-2006-02-002477)
28. Lill M, Koks S, Soomets U, Schalkwyk LC, Fernandes C, Lutsar I, Taba P. 2013 Peripheral blood RNA gene expression profiling in patients with bacterial meningitis. Front. Neurosci. 7, 33. (doi:10.3389/ fnins.2013.00033)
29. Popper SJ, Watson VE, Shimizu C, Kanegaye JT, Burns JC, Relman DA. 2009 Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection. J. Infect. Dis. 200, 657-666. (doi:10.1086/603538)
30. Zaas AK et al. 2009 Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 6, 207-217. (doi:10.1016/j.chom.2009. 07.006)
31. Mejias A et al. 2013 Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection. PLoS Med. 10, e1001549. (doi:10.1371/journal. pmed.1001549)
32. Koh GC, Schreiber MF, Bautista R, Maude RR, Dunachie S, Limmathurotsakul D, Day NP, Dougan G, Peacock SJ. 2013 Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling. PLoS ONE 8, e54961. (doi:10.1371/journal.pone. 0054961)
33. Ubol S, Masrinoul P, Chaijaruwanich J, Kalayanarooj S, Charoensirisuthikul T, Kasisith J. 2008 Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever. J. Infect. Dis. 197, 1459-1467. (doi:10.1086/587699)
34. Nascimento EJ et al. 2009 Gene expression profiling during early acute febrile stage of dengue infection can predict the disease outcome. PLoS ONE 4, e7892. (doi:10.1371/journal.pone. 0007892)
35. Loke P, Hammond SN, Leung JM, Kim CC, Batra S, Rocha C, Balmaseda A, Harris E. 2010 Gene expression patterns of dengue virus-infected children from Nicaragua reveal a distinct signature of increased metabolism. PLoS Neglected Trop. Dis. 4, e710. (doi:10.1371/journal. pntd.0000710)
36. Zhang ZN et al. 2013 Transcriptomic analysis of peripheral blood mononuclear cells in rapid progressors in early HIV infection identifies a signature closely correlated with disease progression. Clin. Chem. 59, 1175-1186. (doi:10. 1373/clinchem.2012.197335)
37. Gupta A, Nagilla P, Le HS, Bunney C, Zych C, Thalamuthu A, Bar-Joseph Z, Mathavan S, Ayyavoo V. 2011 Comparative expression profile of miRNA and mRNA in primary peripheral blood mononuclear cells infected with human immunodeficiency virus (HIV-1). PLoS ONE 6, e22730. (doi:10.1371/journal.pone. 0022730)
38. Teles RM et al. 2013 Type I interferon suppresses type II interferon-triggered human antimycobacterial responses. Science 339, 1448-1453. (doi:10.1126/science.1233665)
39. Ardura MI et al. 2009 Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections. PLoS ONE 4, e5446. (doi:10.1371/journal. pone.0005446)
40. Liu K, Chen L, Kaur R, Pichichero M. 2012 Transcriptome signature in young children with acute otitis media due to Streptococcus pneumoniae. Microbes Infect. Inst. Pasteur 14, 600-609. (doi:10. 1016/j.micinf.2012.01.006)
41. Thompson LJ et al. 2009 Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi. Proc. Natl Acad. Sci. USA 106, 22 433-22 438. (doi:10.1073/pnas. 0912386106)
42. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, Mollenkopf HJ, Ziegler A, Kaufmann SH. 2007 Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J. Mol. Med. 85, 613-621. (doi:10.1007/s00109-007-0157-6)
43. Mistry R et al. 2007 Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J. Infect. Dis. 195, 357-365. (doi:10. 1086/510397)
44. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, Black G, Walzl G, Kaufmann SH. 2011 Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun. 12, 15-22. (doi:10.1038/gene.2010.51)
45. Lesho E et al. 2011 Transcriptional responses of host peripheral blood cells to tuberculosis infection. Tuberculosis 91, 390-399. (doi:10.1016/j.tube. 2011.07.002)
46. Maertzdorf J, Ota M, Repsilber D, Mollenkopf HJ, Weiner J, Hill PC, Kaufmann SH. 2011 Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis. PLoS ONE 6, e26938. (doi:10.1371/journal.pone.0026938)
47. Maertzdorf J, Weiner 3rd J, Mollenkopf HJ, Network TB, Bauer T, Prasse A, Muller-Quernheim J, Kaufmann SH. 2012 Common patterns and diseaserelated signatures in tuberculosis and sarcoidosis. Proc. Natl Acad. Sci. USA 109, 7853-7858. (doi:10. 1073/pnas.1121072109)
48. Cliff JM et al. 2013 Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J. Infect. Dis. 207, 18-29. (doi:10.1093/ infdis/jis499)
49. Kaforou M et al. 2013 Detection of tuberculosis in HIV-infected and-uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med. 10, e1001538. (doi:10. 1371/journal.pmed.1001538)
50. Querec TD et al. 2009 Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10, 116-125. (doi:10. 1038/ni.1688)
51. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MPR. 2013 The immune response in tuberculosis. Annu. Rev. Immunol. 31, 475-527. (doi:10.1146/annurev-immunol-032712-095939)
52. Annonymous. 2012 Global tuberculosis report 2012. Geneva, Switzerland: World Health Organisation.
53. Annonymous. 2010 The global plan to Stop TB 2011-2015. Geneva, Switzerland: World Health Organisation.
54. Vynnycky E, Fine PE. 2000 Lifetime risks, incubation period, and serial interval of tuberculosis. Am. J. Epidemiol. 152, 247-263. (doi:10.1093/aje/ 152.3.247)
55. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM. 2001 Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345, 1098-1104. (doi:10.1056/ NEJMoa011110)
56. Havlir DV, Barnes PF. 1999 Tuberculosis in patients with human immunodeficiency virus infection. N. Engl. J. Med. 340, 367-373. (doi:10.1056/ NEJM199902043400507)
57. Breen RA et al. 2006 Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection. Thorax 61, 791-794. (doi:10.1136/thx.2006.058867)
58. Pitt JM, Blankley S, McShane H, O'Garra A. 2013 Vaccination against tuberculosis: how can we better BCG? Microb. Pathog. 58, 2-16. (doi:10.1016/j. micpath.2012.12.002)
59. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. 1994 Efficacy of BCG vaccine in the prevention of tuberculosis. Metaanalysis of the published literature. J. Am. Med. Assoc. 271, 698-702. (doi:10.1001/jama.1994. 03510330076038)
60. Fine PE. 1995 Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346, 1339-1345. (doi:10.1016/S0140-6736(95)92348-9)
61. Mangtani P et al. 2013 Protection by BCG against tuberculosis: a systematic review of randomised controlled trials. Clin. Infect. Dis. 58, 470-480. (doi:10.1093/cid/cit790)
62. Kagina BM et al. 2010 Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns. Am. J. Respir. Crit. Care Med. 182, 1073-1079. (doi:10.1164/rccm.201003-0334OC)
63. Kaufmann SH. 2012 Tuberculosis vaccine development: strength lies in tenacity. Trends Immunol. 33, 373-379. (doi:10.1016/j.it.2012. 03.004)
64. Tameris MD et al. 2013 Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 381, 1021-1028. (doi:10.1016/S0140-6736(13) 60177-4)
65. Scriba TJ et al. 2011 Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCGvaccinated infants. J. Infect. Dis. 203, 1832-1843. (doi:10.1093/infdis/jir195)
66. Verreck FA et al. 2009 MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. PLoS ONE 4, e5264. (doi:10.1371/journal.pone. 0005264)
67. Berry MP, Blankley S, Graham CM, Bloom CI, O'Garra A. 2013 Systems approaches to studying the immune response in tuberculosis. Curr. Opin. Immunol. 25, 579-587. (doi:10.1016/j.coi.2013. 08.003)
68. Lu C et al. 2011 Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells. PLoS ONE 6, e24290. (doi:10. 1371/journal.pone.0024290)
69. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, Barry 3rd CE, Freedman VH, Kaplan G. 2001 Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc. Natl Acad. Sci. USA 98, 5752-5757. (doi:10.1073/ pnas.091096998)
70. Manca C, Tsenova L, Freeman S, Barczak AK, Tovey M, Murray PJ, Barry C, Kaplan G. 2005 Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J. Interferon Cytokine Res. 25, 694-701. (doi:10. 1089/jir.2005.25.694)
71. Joosten SA, Fletcher HA, Ottenhoff TH. 2013 A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis. PLoS ONE 8, e73230. (doi:10.1371/ journal.pone.0073230)
72. Koth LL, Solberg OD, Peng JC, Bhakta NR, Nguyen CP, Woodruff PG. 2011 Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. Am. J. Respir. Crit. Care Med. 184, 1153-1163. (doi:10.1164/rccm.201106-1143OC)
73. Zhao S, Fung-Leung WP, Bittner A, Ngo K, Liu X. 2014 Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells. PLoS ONE 9, e78644. (doi:10.1371/journal.pone. 0078644)
74. Wang Z, Gerstein M, Snyder M. 2009 RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10, 57-63. (doi:10.1038/nrg2484)
75. Churbanov A, Milligan B. 2012 Accurate diagnostics for bovine tuberculosis based on high-throughput sequencing. PLoS ONE 7, e50147. (doi:10.1371/ journal.pone.0050147)
76. Sheridan C. 2014 Milestone approval lifts Illumina's NGS from research into clinic. Nat. Biotechnol. 32, 111-112. (doi:10.1038/ nbt0214-111)
77. Sambarey A, Prashanthi K, Chandra N. 2013 Mining large-scale response networks reveals 'topmost activities' in Mycobacterium tuberculosis infection. Sci. Rep. 3, 2302. (doi:10. 1038/srep02302)